Cytosorbents (CTSO) Operating Income (2011 - 2026)
Cytosorbents (CTSO) reported Operating Income of -$3.0 million for Q1 2026, up 21.71% on a YoY basis from -$2.5 million in Q1 2025, and up 30.58% quarter-over-quarter from -$4.4 million in Q4 2025.
Cytosorbents (CTSO) Operating Income (2011 - 2026) Analysis & Trends
Cytosorbents has reported Operating Income for 16 years, with the latest figure at -$3.0 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income rose 21.71% year-over-year to -$3.0 million; the trailing twelve-month figure through Mar 2026 stood at -$13.9 million (up 11.33% YoY), and the FY2025 full-year result was -$14.7 million, up 10.35% from the prior year.
- Operating Income for Q1 2026 stood at -$3.0 million, up from -$4.4 million in the prior quarter.
- The five-year high for Operating Income was -$2.9 million in Q3 2025, with the low at -$9.4 million in Q4 2023.
- Historically, Operating Income has averaged -$5.7 million across 5 years, with a median of -$4.8 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Income sank 173.16% — and 2024, when it jumped 63.91%.
- Cytosorbents' Operating Income stood at -$6.4 million in 2022, then tumbled by 48.01% to -$9.4 million in 2023, then jumped by 63.91% to -$3.4 million in 2024, then fell by 29.16% to -$4.4 million in 2025, then jumped by 30.58% to -$3.0 million in 2026.
- The last three Operating Income figures came in at -$3.0 million (Q1 2026), -$4.4 million (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 477.60 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 515.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 282.15 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 255.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Cytosorbents | 25.72 Mn | 20.92 Mn | 6.13 Mn | -3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.04 Mn |
| Dec 31, 2025 | -4.39 Mn |
| Sep 30, 2025 | -2.86 Mn |
| Jun 30, 2025 | -3.62 Mn |
| Mar 31, 2025 | -3.89 Mn |
| Dec 31, 2024 | -3.40 Mn |
| Sep 30, 2024 | -4.83 Mn |
| Jun 30, 2024 | -3.57 Mn |
| Mar 31, 2024 | -4.66 Mn |
| Dec 31, 2023 | -9.41 Mn |
| Sep 30, 2023 | -7.35 Mn |
| Jun 30, 2023 | -6.56 Mn |
| Mar 31, 2023 | -7.89 Mn |
| Dec 31, 2022 | -6.36 Mn |
| Sep 30, 2022 | -9.02 Mn |
| Jun 30, 2022 | -8.36 Mn |
| Mar 31, 2022 | -7.79 Mn |
| Dec 31, 2021 | -9.56 Mn |
| Sep 30, 2021 | -5.41 Mn |
| Jun 30, 2021 | -4.92 Mn |